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Abstract
Background: Asthma is a complex genetic disease with more than 20 genome-wide scans
conducted so far. Regions on almost every chromosome have been linked to asthma and several
genes have been associated. However, most of these associations are weak and are still awaiting
replication.
Methods: In this study, we conducted a second-stage genome-wide scan with 408 microsatellite
markers on 201 asthma-affected sib pair families and defined clinical subgroups to identify
phenotype-genotype relations.
Results: The lowest P value for asthma in the total sample was 0.003 on chromosome 11, while
several of the clinical subsets reached lower significance levels than in the overall sample. Suggestive
evidence for linkage (p = 0.0007) was found for total IgE on chromosomes 1, 7 and again on
chromosome 11, as well as for HDM asthma on chromosome 12. Weaker linkage signals could be
found on chromosomes 4 and 5 for early onset and HDM, and, newly described, on chromosome
2 for severe asthma and on chromosome 9 for hay fever.
Conclusions: This phenotypic dissection underlines the importance of detailed clinical
characterisations and the extreme genetic heterogeneity of asthma.
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Many chromosomal regions have been shown to be
linked or associated to asthma and asthma-associated
traits in humans [1]. More recently, asthma genes have
been identified on chromosomes 2 [2], 13 [3], 14 [4], and
20 [5]. The investigation of the genetic aetiology aims at
the improvement of preventive strategies, diagnostic tools
and therapeutic alternatives [6]. These final steps have not
yet been reached or are even in sight, while the reasons for
this delay are unclear.
The mainstay of all genetic studies has been genome-wide
linkage scans in families with at least two asthma-affected
siblings. Based on a previous analysis of a genome-wide
scan of asthma [7,8] with inconsistent chromosomal find-
ings to earlier studies, we decided to expand the initial
sample with additional families by the same core protocol
for clinical examination and using the same set of micro-
satellite markers [7,8]. The increased the number of iden-
tically pheno- and genotyped families could be used to
define sub-phenotypes, which may be a promising strat-
egy to explain the aetiological heterogeneity observed so
far. Relevant clinical subsets may be defined by different
age of onset, different disease course by degree of severity,
extrinsic (allergic sensitization detectable) and intrinsic
(no allergic sensitization detectable, symptoms often dur-
ing infections of the upper respiratory tract) asthma type,
and house dust mite allergy (HDM), as well as genetic
background as judged by geographical origin of parents
(table 1). We hypothesized that the restriction to a smaller
well-defined sample would reduce heterogeneity and
improve the power of detecting linkage. Linkage regions
should show higher lod scores than in the total sample
and lead from phenotype subgroups to a genotypic
dissection.
Methods
Clinical evaluation
97 families consisting of at least two children with con-
firmed clinical asthma were collected during the first stage
of the German genome scan [7]. We now recruited
another set of families during a period of 18 months.
Trained staff from 3 university hospitals as well as 6 pedi-
atric pulmonary practices carried out an identical pheno-
typing procedure as described previously [7]. This
procedure contained detailed interviews of every family
member, skin prick tests (SPT) of frequent allergens,
blood samples (for IgE and allergen-specific IgE (RAST)
measurements, eosinophil count), peak flow tests for a
period of 10 days and dust collection at patients' homes.
SPT and RAST assays included several pollens, animal
furs, mould, and house dust mite allergens (ALK-
SCHERAX, Hamburg, Germany). The ethics commission
of "Nordrhein-Westfalen" approved all study methods
and informed consent was obtained from all parents and
children.
Children with premature birth, low birth weight and any
severe pulmonary disease other than asthma were
excluded as prematurity (and or associated low birth
weight) may be a major non-genetic risk factor for the
development of pulmonary symptoms. Another 4
families were excluded after genotyping because of Men-
delian errors. The additional 104 families comprised 452
individuals (table 2). Their 244 children had a mean age
of 10.8 years. 75 families contributed 2 children, 22 fam-
ilies 3 children and 7 families 4 children). In total, the 201
families had 465 children; 255 were male, 210 female,
and 413 had physician-diagnosed asthma.
The trait "asthma" was based on the clinical diagnosis as
described earlier [7]. "lnIgE" was used for analysis as a
quantitative variable and categorized by cut-off point of
100 kU/l. Furthermore, the following phenotype subsets
(see also table 1) were selected from the total study
sample:
Table 1: Phenotypes of the 201 families included.
Phenotype Definition No. of families
Early onset asthma occurrence of asthmatic symptoms for one child before the age of 2 years and for his 
or her sib pair at least before the age of 4 years
67
Extrinsic asthma all asthmatic children are positive for at least one SPT or specific IgE 134
HDM SPT positive at least 3 family members with a positive skin prick test (SPT) for HDM 33
HDM RAST positive at least 3 family members with a positive result of serum specific IgE for HDM 42
Severe asthma asthma severity index (see table 3) for one asthmatic child is 4 or 5 and for his or her 
sib pair 3, 4 or 5
56
Seasonal variation: "Winter-Type" one affected child suffers from asthma attacks in the winter half-year and his or her 
sib pair at least not solely in the summer half-year
39
Seasonal variation: "Summer-Type" one affected child suffers from asthma attacks in the winter half-year and his or her 
sib pair at least not solely in the summer half-year
35
German nationality both parents are of German descent 170Page 2 of 10
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We created a subset of 67 families with one child having
asthma symptoms before the age of 2 years and another
child having asthma symptoms before the age of 4 years.
In about half of the families within this subtype, both
affected children had asthmatic symptoms before the age
of 2 years. We were of course dependent on the recollec-
tion of the parents – but keeping in mind that the state of
health of the children is of high priority in those families
who joined our study and the period of time is quite clear,
the data seemed valuable to us.
Extrinsic/intrinsic asthma sample
The group of families with atopic ("extrinsic") asthma was
large, consisting of 134 families all with at least one posi-
tive skin prick test reaction or one increased specific IgE.
Positive Dermatophagoides farinae skin prick test and increased 
specific IgE in serum
Almost all family members participated in a skin prick test
(SPT). We selected an "HDM SPT positive" group of 33
families with at least 3 family members showing a skin
prick test reaction ≥ 3 mm. House dust mite allergy is
quite common in asthmatic patients, and a known trigger
factor for asthma attacks. Some studies have successfully
used the combination with asthma as lead trait [9,10]. As
the functional relevance might be slightly different in
study participants with serum antibodies, another sub-
group was based on the measurement of HDM-positive
specific IgE at concentrations ≥ 0.35 kU/l, which resulted
in a group of 42 families.
Asthma severity
Several interview questions related to asthma symptoms,
diagnostic findings and therapy. We used information
about asthma attack frequency, actual medication and
emergency hospital visits for a severity index with 5 levels.
This index is based on subjective patient information, cur-
rent/previous therapy and influence on quality of life
(table 3). "Severe Asthma" was seen in 56 families where
one sib had at least grade 4 and another grade 3, 4 or 5.
"Moderate Asthma" with one sib of maximum grade 2
and another with maximum grade 3 was defined in the
same way.
Table 2: Clinical characteristics of the 201 families (867 participants) that also include non-affected siblings of the core families. 
Descriptors of categorical variables include n/total sample in the first row and percent in the second row. Descriptors of continuous 
variables include mean values in the first row and standard deviation in the second row.
Parents Children
Stage 1 Stage 2 Stage 1 Stage 2
sex females 97/194
50.0%
104/208
50.0%
96/221
43.4%
114/244
46.7%
Asthma diagnosis 33/194
17.0%
60/208
28.8%
200/221
90.5%
213/244
87.3%
D.pter skin > = 3 mm 68/193
35.2%
58/206
28.2%
111/217
51.2%
107/242
44.2%
D.far skin > = 3 mm 57/193
29.5%
48/207
23.2%
101/217
46.5%
88/242
36.4%
D.pter. CAP class >1 51/183
27.9%
43/147
29.3%
124/217
57.1%
102/198
51.5%
D.far. CAP class >1 46/183
25.1%
39/147
26.5%
122/217
56.2%
100/198
50.5%
age (years) 39.8
+/-5.7
40.9
+/-5.5
11.0
+/-4.2
10.8
+/-3.4
onset asthma (years) not reliable not reliable 3.8
+/-2.8
4.3
+/-3.1
height (cm) 172.3
+/-9.0
172.3
+/- 9.9
146.9
+/-19.2
156.3
+/-18.1
weight (kg) 76.0
+/-14.9
78.0
+/-16.6
41.5
+/-17.0
47.4
+/-16.6
ln(Ige) (kU/L) 4.1
+/-1.7
4.1
+/-1.6
5.0
+/-2.0
5.0
+/-1.8
ln(eosinophil) (count / mm3) 0.3
+/-1.7
0.7
+/-1.5
1.1
+/-1.6
1.1
+/-1.6
FEV1 (ml) 3.594
+/-804
3.464
+/- 957
2.312
+/-883
2.861
+/-1.061Page 3 of 10
(page number not for citation purposes)
BMC Pulmonary Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2466/5/1Seasonal variation of asthma attacks
All participants were asked to specify the months when
asthma attacks occurred. 39 "winter-type" families had
one affected child with symptoms only in the cold
months and his or her sibs not a fully "summer-type". In
contrast 35 "summer-type" families were found with one
affected child with summer attacks and his or her sibs not
purely "winter-type". Attacks year-round usually were
seen with severe disease only. Sporadic attacks usually did
not have any seasonal preferences while both the intrin-
sic, usually infection-related "winter-type", as well as the
extrinsic, hay fever related "summer-type", appeared to be
concordant within families. This observation may already
support the hypothesis of different genes in different
subtypes.
German sample
In 170 of 201 families, both parents were of German
descent ("German"). In this subgroup, we tried to reduce
the genetic heterogeneity by leaving out the remaining 31
families, of which 5 were from Sweden and 5 from Turkey.
DNA analysis
DNA was isolated from peripheral white blood cells using
the Puregene DNA isolation kit (Gentra Systems, Minne-
apolis, MN) according to the manufacturer's recommen-
dation. For genotyping we used almost the same
microsatellite marker as in the first scan [7,8]. The final
analysis included 408 markers of which 364 were auto-
somal and 7 were based on the X-chromosome, all
included in the previous scan as well as a set of 37 previ-
ous fine mapping markers. For the baseline marker set, the
mean distance was 10 cM, with an average marker-infor-
mation content of 0.87 and a mean heterozygosity of
0.79.
Marker amplification was performed in microtiter plates,
either in 96- (Peltier Thermal Cycler PT-225, MJ Research,
Waltham, MA) or in 384-well format (GeneAmp PCR Sys-
tem 9700, Applied Biosystems, Foster City, CA). Fragment
analysis of PCR pools was conducted on an ABI 3700
DNA sequencer and genotypes were scored using GENES-
CAN and GENOTYPER (ABI) software. In the second
scan, 98% of all possible genotypes could be unequivo-
cally determined.
Statistical analysis
Genotyping data were transferred to a SQL 2000 database,
pre-checked with previously developed routines and
exported in ASCII format for multipoint linkage analysis
with MERLIN 0.9.3 [11]. Allele frequencies were esti-
mated from the (unrelated) parental alleles. As different
primers were used in some assays between the first scan in
1997 and the second scan in 2002, we adjusted the origi-
nal allele size before replacing the allele size with its
respective order. This procedure led to comparable allele
frequency distributions in both scans. For ordering of all
markers we used the Marshfield comprehensive human
genetic linkage map that was slightly modified according
to the marker order given by Golden Path 13 and
expressed intermarker distances to Haldane cM. Error
detection as implemented in MERLIN was then applied to
discard unlikely genotypes from the analysis. Finally, P-
values for qualitative traits were derived from the Kong
and Cox method based on the score statistic S_all [12]. For
the quantitative trait ln(IgE) a variance component was
applied including only age and sex as covariates.
Results
Figure 1 shows the linkage results for asthma, total IgE
and all other subgroups.
Table 3: Asthma severity grade definition.
Severity grade Frequency and 
percentage in 
asthmatic children
Clinical criteria
Attacks (last 12 
months)
Asthma medication 
(last 12 months)
At least 1 overnight 
hospital stay
1 29 (7.2%) none none none
2 118 (29.3%) none none yes
none yes none
3 164 (40.8%) none yes yes
once/month yes none
4 72 (17.9%) once/month yes yes
at least once/month yes none
5 19 (4.7%) at least once/month yes yesPage 4 of 10
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with distance in centimorgans on a linear scale. Table 4
reports all loci with p-values below 0.01 in at least two
adjacent markers for one phenotypic subgroup.
On chromosome 1, two linkage areas for total IgE could
be found at about 55 cM (p = 0.00009) and at 188 cM (p
= 0.0007), which reached the threshold for suggestive
linkage (p = 0.0007) [13]. On chromosome 2 at about 64
cM (p = 0.002) evidence was found for a locus for severe
asthma and for house dust mite sensitive asthma. Early
onset, together with HDM, is represented both on chro-
mosome 4 at about 195 cM (p = 0.002) and on chromo-
some 5 at about 55 cM (p = 0.002).
Three loci for total IgE regulation were found on chromo-
some 7 (65 cM, p = 0.0004) and chromosome 11 (2 cM,
p = 0.0005; 147 cM, p = 0.0002), all with suggestive link-
age according Kruglyak-Lander.
On chromosome 9 at about 104 cM (p = 0.002) there is
evidence for a locus linked to allergic rhinitis plus asthma
("summer-type"), having an effect mainly in families of
German descent. Lastly, a locus showing suggestive link-
age could be identified on chromosome 12 (95 cM, p=
0.0002) for house dust mite sensitised asthmatic patients.
Discussion
Several linkage regions in asthma families could be found
in this extended sample, although again no linkage with P
< 0.003 could be found with any marker for asthma.
Asthma is apparently of such a heterogeneity that even
investigating affected sib pairs from more than 200 fami-
lies failed to yield significant results. Nevertheless, the
quantitative trait IgE in these families, both as a discrete
and continuous variable, led to three suggestive linkage
findings on chromosomes 1, 7, and 11, which have all
been discussed in prior publications (table 5).
Phenotypic dissection
Moreover, the strategy of phenotypic dissection proved to
be quite successful, though the sample size of subsets
seems to be very small. The size of the sample in a linkage
study is known to be one of the most important factors for
a significant finding [1], making the artificial limitation of
subsets a double-edged decision. Clearly, there is a
remarkable phenotypic heterogeneity of asthmatic dis-
eases but – as these families represent different genetic
influences-limitation of the sample size did not affect sta-
tistical properties as significance values were smaller com-
pared to the whole study sample.
In particular, the subgroups segregated by high disease
severity, sensitisation by HDM, early onset and popula-
tion origin attained better lower significance levels than
the main trait (table 4). So far, results were not adjusted
with the Bonferroni correction for multiple testing as this
would have been too conservative for this explorative
investigation. Subgroups are often closely related and
highly overlapping. Nevertheless, there might be a prob-
lem with multiple testing and the criteria for suggestive
linkage in a genome scan on a single phenotype [13].
Sample recruitment with restricted phenotypic require-
ments proved to be successful for some other traits as well.
Early onset definitions have been used for cancer studies
and metabolic disorders to increase the underlying genetic
component [27,28]. Separation in sub-samples of ethni-
cally diverse populations has also been conducted [26],
but higher disease activity scores [29] seemed to give an
advantage in other fields also.
Other Asthma Genome Scans
Recently, evidence was shown for asthma genes on chro-
mosomes 2 [2], 13 [3], 14 [4], and 20 [5]. Our study does
not support linkage loci in those regions. As the region on
chromosome 13 was responsible for only 10% of the
observed IgE serum level variability, this small effect may
be easily overlooked in another study. A lack of replica-
tion does not necessarily mean an error in the primary
study. Most likely, genetic heterogeneity is the cause,
where the proportion of patients with a particular gene
variant is different between studies. A polygenic model of
the inheritance mode of asthma with minor effects by sin-
gle genes could explain the highly diverse association and
linkage results thus far.
Frequent replication, however, may point toward lead
genes. Most regions listed in table 4 have already been
described and some of the traits are supported by the phe-
notypes proposed in our analysis. Table 5 summarizes
previously published asthma/atopy loci in approx. 20 cM
distance that would be consistent with our findings. Both
loci on chromosomes 4 and 5 are supported by the
phenotypes of early onset, HDM and "winter-type", which
might relate to the clinical picture of chronic obstructive
bronchitis. Phenotypes described by other studies include
lung function variation and HDM, which is supported by
our data. The "atopy" locus (defined by SPT and RAST) on
chromosome 3 confirms linkage studies of atopic derma-
titis (AD) [14] and might be the genetic link between both
diseases.
The locus on chromosome 12 with suggestive linkage for
HDM in our study is known from many other reports.
Also our first scan showed weak evidence for linkage in
this region at D12S351 (p = 0.01) [7], whereas the best
result for the HDM subset lies now about 0.5 cM apart at
D12S95 with p = 0.0002. These consistent findings are
probably based on frequent alleles playing an importantPage 5 of 10
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BMC Pulmonary Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2466/5/1Multipoint linkage results for all traitsFigure 1
Multipoint linkage results for all traits. Chromosomes are arranged with increasing numbers with orientation from p-ter to q-
ter. Distance is given in centimorgans (cM) on a linear scale. A = asthma all, B = asthma German families, C = extrinsic asthma, 
D = HDM RAST positive, E = HDM SPT positive, F = severe asthma, G = early onset asthma, H = winter-type, I = summer-
type, J = LnIgE continuous, K = LnLgE categorical.
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BMC Pulmonary Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2466/5/1Table 4: Linkage results in 201 core families with at least 2 children having asthma. Weak linkage (p < 0.01) and suggestive linkage (p = 
0.0007) is indicated in bold.
GDB PIC Chr. cM 
(Marshfield)
Asthma 
All
Asthma 
German
Extrinsic 
Asthma
HDM 
RAST +ve
HDM 
SPT +ve
Severe 
Asthma
Early 
Onset
Winter-
Type
Summer-
Type
Ln(IgE) 
continuous
Ln(IgE) 
categorical
D1S478 0.8404 1 48.53 0.03 0.03 0.04 0.5 0.9 0.12 0.3 0.13 0.8 0.002 0.0011
D1S234 0.8559 1 55.1 0.07 0.08 0.04 0.3 0.9 0.12 0.2 0.2 0.8 0.0002 0.00009
D1S255 0.7710 1 65.47 0.005 0.04 0.0015 0.04 0.4 0.03 0.15 0.7 0.2 0.002 0.005
D1S197 0.8285 1 76.27 0.007 0.06 0.002 0.12 0.4 0.09 0.07 0.5 0.11 0.08 0.2
D1S484 0.8050 1 169.68 0.08 0.12 0.012 0.004 0.003 0.3 0.3 0.08 0.3 0.007 0.013
D1S431 0.9008 1 182.35 0.12 0.13 0.02 0.03 0.04 0.5 0.3 0.3 0.2 0.005 0.005
D1S2815 0.9201 1 188.85 0.06 0.09 0.012 0.06 0.07 0.3 0.3 0.2 0.03 0.0008 0.0007
D1S238 0.8722 1 202.73 0.4 0.7 0.4 0.2 0.1 0.3 0.8 0.2 0.6 0.004 0.003
D1S2655 0.8976 1 216.82 0.7 0.9 0.6 0.2 0.2 0.2 0.9 0.7 0.7 0.05 0.007
D2S2374 0.9039 2 54.96 0.03 0.07 0.04 0.011 0.008 0.04 0.02 0.8 0.4 0.3 0.5
D2S2328 0.9545 2 61 0.02 0.04 0.014 0.007 0.007 0.008 0.04 0.8 0.06 0.14 0.4
D2S2294 0.9617 2 64.84 0.02 0.03 0.02 0.003 0.02 0.003 0.5 0.8 0.02 0.13 0.4
D2S2298 0.9585 2 65.94 0.02 0.02 0.02 0.003 0.02 0.002 0.06 0.8 0.014 0.11 0.3
D2S2113 0.9331 2 88.15 0.3 0.5 0.3 0.2 0.4 0.008 0.13 0.7 0.3 0.5 0.5
D3S1597 0.8199 3 29.92 0.7 0.7 0.4 0.6 0.9 0.4 0.4 0.6 0.8 0.009 0.006
D3S1286 0.9021 3 41.56 0.4 0.3 0.3 0.2 0.3 0.13 0.2 1 0.4 0.02 0.007
D3S1300 0.8748 3 80.32 0.12 0.3 0.2 0.09 0.0014 0.3 0.5 0.3 0.8 0.4 0.09
D3S1285 0.7673 3 91.18 0.07 0.08 0.2 0.07 0.0008 0.2 0.2 0.13 0.6 0.5 0.5
D4S1607 0.8843 4 183.63 0.3 0.3 0.3 0.07 0.05 0.2 0.005 0.07 0.6 0.4 0.3
D4S1535 0.8938 4 195.06 0.05 0.07 0.013 0.009 0.03 0.03 0.006 0.007 0.11 0.07 0.09
D4S2924 0.8934 4 199.93 0.06 0.09 0.007 0.002 0.03 0.02 0.009 0.02 0.2 0.08 0.15
D5S426 0.8990 5 51.99 0.006 0.006 0.03 0.008 0.14 0.04 0.002 0.007 0.2 0.09 0.4
D5S418 0.9101 5 58.55 0.015 0.03 0.06 0.004 0.2 0.012 0.007 0.012 0.4 0.02 0.07
D7S484 0.9204 7 53.5 0.5 0.7 0.2 0.4 0.5 0.5 0.4 0.5 0.9 0.02 0.009
D7S528 0.9481 7 57.79 0.2 0.4 0.014 0.14 0.3 0.3 0.5 0.5 0.6 0.0012 0.0007
D7S510 0.9783 7 59.93 0.14 0.4 0.02 0.3 0.3 0.2 0.6 0.6 0.4 0.0009 0.0013
D7S485 0.9688 7 60.68 0.1 0.3 0.01 0.3 0.3 0.13 0.6 0.7 0.4 0.0007 0.0004
D7S2548 0.9596 7 62.28 0.2 0.4 0.05 0.4 0.5 0.12 0.7 0.7 0.3 0.003 0.002
D7S691 0.9403 7 63.67 0.08 0.2 0.02 0.4 0.5 0.08 0.6 0.6 0.3 0.003 0.007
D7S2506 0.9313 7 69.56 0.2 0.4 0.13 0.9 0.8 0.14 0.7 0.7 0.3 0.007 0.011
D7S663 0.9049 7 78.65 0.06 0.05 0.08 0.3 0.4 0.2 0.5 0.3 0.14 0.0007 0.001
D7S669 0.8351 7 90.42 0.08 0.05 0.04 0.4 0.2 0.13 0.5 0.5 0.02 0.0014 0.0012
D9S257 0.9630 9 91.87 0.09 0.06 0.3 0.3 0.4 0.4 0.4 0.4 0.004 0.5 0.5
D9S283 0.9681 9 94.85 0.015 0.01 0.1 0.2 0.3 0.2 0.11 0.1 0.002 0.2 0.3
D9S1796 0.9745 9 97.53 0.02 0.014 0.07 0.3 0.2 0.05 0.07 0.14 0.006 0.07 0.13
D9S1781 0.9565 9 99.4 0.015 0.007 0.05 0.14 0.2 0.11 0.03 0.03 0.003 0.07 0.15
D9S1851 0.9708 9 103.42 0.02 0.008 0.04 0.06 0.2 0.2 0.05 0.02 0.003 0.3 0.5
D9S1786 0.9825 9 104.48 0.013 0.006 0.03 0.04 0.11 0.13 0.05 0.02 0.002 0.4 0.5
D9S176 0.9798 9 105.02 0.02 0.009 0.05 0.09 0.1 0.2 0.14 0.03 0.005 0.5 0.5
D9S1690 0.9709 9 106.63 0.06 0.04 0.2 0.2 0.14 0.4 0.4 0.13 0.007 0.5 0.5
D9S1784 0.9667 9 111.99 0.11 0.04 0.2 0.07 0.2 0.3 0.6 0.4 0.008 0.5 0.5
D10S547 0.8313 10 29.15 0.14 0.2 0.4 0.8 0.8 0.6 0.3 0.2 0.9 0.007 0.005
D10S191 0.8726 10 37.9 0.4 0.5 0.2 0.3 0.5 0.8 0.5 0.3 0.8 0.008 0.012
D11S922 0.9045 11 2.11 0.2 0.4 0.4 0.3 0.02 0.13 0.3 0.9 0.06 0.0005 0.0006
D11S902 0.8133 11 21.47 0.3 0.3 0.5 0.9 0.3 0.3 0.5 0.6 0.5 0.006 0.003
D11S935 0.7997 11 45.94 0.5 0.4 0.4 0.4 0.4 0.4 0.6 0.9 0.05 0.003 0.04
D11S968 0.8094 11 147.77 0.003 0.007 0.05 0.11 0.3 0.04 0.12 0.6 0.2 0.0005 0.0002Page 7 of 10
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for HDM were quite similar, but the HDM SPT positive
group – which is a smaller group-, reached the suggestive
linkage level on chromosome 12. SPT, even more than
RAST, might represent the individual's allergic
disposition.
On chromosome 2, we found a locus in families with
severe asthma that has not yet been described in other
studies. A p-value of 0.007 has already been found in our
first genome-wide scan [7] for D2S2298 and our main
trait asthma. The same marker for severe asthma in both
samples improved to a p-value of 0.002. Severe asthma is
D12S355 0.8343 12 74.58 0.07 0.08 0.06 0.003 0.04 0.4 0.2 0.012 0.6 0.3 0.4
D12S1684 0.9339 12 86.4 0.02 0.015 0.05 0.002 0.05 0.9 0.15 0.2 0.4 0.08 0.4
D12S1667 0.9727 12 92.89 0.05 0.08 0.2 0.003 0.04 0.8 0.15 0.08 0.4 0.03 0.2
D12S81 0.9707 12 94.44 0.08 0.12 0.2 0.005 0.02 0.8 0.3 0.09 0.3 0.013 0.2
D12S351 0.9822 12 95.56 0.02 0.013 0.05 0.002 0.0003 0.5 0.3 0.05 0.3 0.0009 0.02
D12S95 0.9785 12 96.09 0.012 0.007 0.04 0.002 0.0002 0.5 0.2 0.06 0.4 0.0012 0.02
D12S327 0.9757 12 97.78 0.02 0.008 0.07 0.008 0.0009 0.4 0.05 0.13 0.2 0.04 0.2
D12S1716 0.9590 12 101.45 0.04 0.005 0.2 0.02 0.006 0.4 0.06 0.2 0.2 0.011 0.06
D12S1706 0.9696 12 104.12 0.12 0.015 0.3 0.07 0.06 0.6 0.3 0.4 0.2 0.007 0.2
Table 5: Comparison of asthma loci
Chr. 
Position
This study 
(2004)
Bradley 
(2002) [14]
Cookson 
(2001)[15]
Daniels 
(1996) [16]
Dizier 
(2000) [17]
Laitinen 
(2001) [18]
Malerba 
(1999) [19]
Ober 
(1998. 
1999, 2000) 
[20-22]
Xu J (2000, 
2001) [23, 24]
Xu X 
(2001) [25]
Yokouchi 
(2000) [9]
CSGA 
(1997) [26]
1 55cM IgE Asthma Asthma, 
Atopy
Asthma 
Hispanic 
population
1 188cM IgE AD Slope IgE
2 64cM severe 
asthma 
HDM
3 50cM IgE HDM AD Loose 
Asthma
4 195cM early onset 
HDM
Slope HDM and 
Asthma
5 55cM early onset 
HDM
Slope BHR Asthma
7 65cM IgE IgE, Slope, 
Eosinophils
SPT Asthma, IgE
9 104cM German 
summer 
type
Asthma 
symptoms, 
Atopy
11 2cM IgE IgE SPT Asthma 
Hispanic 
population
Asthma
11 147cM IgE IgE
12 95cM HDM Eosino-
phils, IgE
Asthma Asthma IgE, Asthma HDM and 
Asthma
Asthma
Table 4: Linkage results in 201 core families with at least 2 children having asthma. Weak linkage (p < 0.01) and suggestive linkage (p = 
0.0007) is indicated in bold. (Continued)Page 8 of 10
(page number not for citation purposes)
BMC Pulmonary Medicine 2005, 5:1 http://www.biomedcentral.com/1471-2466/5/1rather rare, and a disease-aggravating allele on chromo-
some 2 could be easily overlooked in a heterogeneous
asthma sample. Severe asthma may be a lethal disease,
while a severe-asthma gene would be of high importance
for intensified treatment.
The German "summer-type" locus on chromosome 9 is
also not frequent in other studies. This might be due to the
fact that many, but not all, genes are necessary for a com-
mon trait. Our first asthma scan has already shown link-
age in this region with a p-value of 0.007 for D9S1784 [7],
which now improves to p = 0.002 for the "summer-type"
subset at D9S1786, about 7.5 cM apart.
Conclusions
We conclude that this phenotypic dissection is a useful
tool to detect linkage in a heterogeneous disease like
asthma because some of the sub phenotypes reached even
better significance values than the main trait. We show
that the precision of the phenotype can be more effective
than expanding the sample size only. Unfortunately, large
sample sizes are needed to assure at least moderate sample
size in subsets. Grouping by early onset or disease severity
could be applied to almost every complex disease, but for
a more specific dissection, clinical expert knowledge is
required. A prior analysis of clinical data can help to iden-
tify symptom clustering, which -if consistent within fami-
lies- can reduce genetic heterogeneity.
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